IP Library Granted Patent US 9,568,470
Granted Patent B2
US 9,568,470 · App. 14/437,568 · Granted Feb 14, 2017

Method for increasing the sensitivity of immunoassay system through pretreatment of urine with denaturant

Inventors: Hiroyuki Kurosawa (Niigata, JP); Yoshiaki Hirayama (Niigata, JP)
Assignee: Denka Seiken Co., Ltd.
G01N33/5306G01N2333/705
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,568,470
App. No.
14/437,568
Granted
Feb 14, 2017
Kind
B2
Abstract

An object of the present invention is to provide a method for increasing the sensitivity of an immunoassay system. In order to achieve the object, the present inventors have discovered that the sensitivity of an immunoassay system can be increased by pretreating urine and thus have completed the present invention.

Claims (6)

1. An immunoassay method for measuring a protein in a urine specimen, comprising pretreating the urine specimen by mixing the urine specimen with cysteine and urea, or cysteine and sodium n-dodecylbenzenesulfonate (SDBS), and then measuring the protein in the urine specimen by performing immunoassay, thereby improving assay sensitivity for the protein.

2. The immunoassay method according to claim 1 , comprising pretreating the urine specimen by mixing the urine specimen with 0.0625 mM to 16 mM cysteine and 5 mM to 320 mM urea, or 0625 mM to 16 mM cysteine and 1.43 mM to 5.74 mM sodium n-dodecylbenzenesulfonate (SDBS), and then measuring the protein in the urine specimen by performing immunoassay.

3. The immunoassay method according to claim 1 , wherein the protein is megalin.

4. An immunoassay method for measuring a protein in a urine specimen, comprising pretreating the urine specimen by mixing the urine specimen with penicillamine and urea or penicillamine and sodium n-dodecylbenzenesulfonate (SDBS), and then measuring the protein in the urine specimen by performing immunoassay, thereby improving assay sensitivity for the protein.

5. The immunoassay method according to claim 4 , comprising pretreating the urine specimen by mixing the urine specimen with 0.0625 mM to 64 mM penicillamine and 5 mM to 320 mM urea, or 0625 mM to 64 mM penicillamine and 1.43 mM to 5.74 mM sodium n-dodecylbenzenesulfonate (SDBS), and then measuring the protein in the urine specimen by performing immunoassay.

6. The immunoassay method according to claim 4 , wherein the protein is megalin.

Assignments (2)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2015
From: KUROSAWA, HIROYUKI; HIRAYAMA, YOSHIAKI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 035467/0766 →
Priority Claims (1)
JP 2012-233891 · Oct 23, 2012 · national
Continuity (1)
Related Publication 20150285791A1 · Oct 8, 2015